Eli Lilly 2007 Annual Report Download - page 116

Download and view the complete annual report

Please find page 116 of the 2007 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

PROXY STATEMENT
114114
an undue administrative burden on the company.
Beginning in the fi rst quarter of 2005, the company has published the following information on our website
(www.lilly.com) for both direct company contributions and employee political action committee (PAC) contributions
to support candidates for political offi ce, political parties, offi cials, or committees in the United States:
• policies and procedures for company and PAC contributions
• contributions to candidates, including information about the candidate's offi ce (for example, state, local, or
federal; House or Senate), party affi liation, state, and district
• contributions to political organizations and Section 527 organizations reported by state.
This information is updated annually. In addition to the information available on our website, detailed corporate
contributions, PAC contribution data, and the company’s direct lobbying expenses are available to the public on the
Federal Election Commission website (http://www.fec.gov/disclosure.shtml) and through individual states’ agen-
cies.
One way we participate in the political process is by maintaining memberships in trade associations specifi c
to business and pharmaceutical industry interests, such as PhRMA (Pharmaceutical Research and Manufactur-
ers Association), BIO (Biotechnology Association), Healthcare Leadership Conference, and Business Roundtable.
In our 2007 Report of Political Financial Support, to be published by April 2008, we will report the names of the
major U.S. trade associations to which Lilly belongs, where our annual membership dues exceed $50,000; we will
also note where we have a board seat. These tax-exempt organizations are all required to disclose their lobbying
expenditures under the Lobbying Act of 1995; they report their lobbying expenditures to the United States Senate
(http://www.senate.gov/pagelayout/legislative/g_three_sections_with_teasers/lobbyingdisc.htm). As we do not
control what portion of the organization’s budget is spent on lobbying, it is the fact of company membership and
support for the trade association, and the trade association’s total lobbying expenditure, that reveals the most
about Lilly's political activities.
The board recommends that you vote AGAINST this proposal.